Global Intravenous Sets Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Intravenous Sets market report explains the definition, types, applications, major countries, and major players of the Intravenous Sets market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Fresenius Kabi

    • CareFusion (Becton Dickinson)

    • Codan

    • Hospira

    • Smiths Medical

    • ICU Medical

    • B Braun

    • Vygon

    • Baxter International

    By Type:

    • Primary IV Sets

    • Secondary IV Sets

    • IV Extensions Sets

    By End-User:

    • Congestive Heart Failure

    • Crohn's Disease

    • Hemophilia

    • Immune Deficiencies

    • Multiple Sclerosis

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Intravenous Sets Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Intravenous Sets Outlook to 2028- Original Forecasts

    • 2.2 Intravenous Sets Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Intravenous Sets Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Intravenous Sets Market- Recent Developments

    • 6.1 Intravenous Sets Market News and Developments

    • 6.2 Intravenous Sets Market Deals Landscape

    7 Intravenous Sets Raw Materials and Cost Structure Analysis

    • 7.1 Intravenous Sets Key Raw Materials

    • 7.2 Intravenous Sets Price Trend of Key Raw Materials

    • 7.3 Intravenous Sets Key Suppliers of Raw Materials

    • 7.4 Intravenous Sets Market Concentration Rate of Raw Materials

    • 7.5 Intravenous Sets Cost Structure Analysis

      • 7.5.1 Intravenous Sets Raw Materials Analysis

      • 7.5.2 Intravenous Sets Labor Cost Analysis

      • 7.5.3 Intravenous Sets Manufacturing Expenses Analysis

    8 Global Intravenous Sets Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Intravenous Sets Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Intravenous Sets Export by Region (Top 10 Countries) (2017-2028)

    9 Global Intravenous Sets Market Outlook by Types and Applications to 2022

    • 9.1 Global Intravenous Sets Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Primary IV Sets Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Secondary IV Sets Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global IV Extensions Sets Consumption and Growth Rate (2017-2022)

    • 9.2 Global Intravenous Sets Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Congestive Heart Failure Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Crohn's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hemophilia Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Immune Deficiencies Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Intravenous Sets Market Analysis and Outlook till 2022

    • 10.1 Global Intravenous Sets Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Intravenous Sets Consumption (2017-2022)

      • 10.2.2 Canada Intravenous Sets Consumption (2017-2022)

      • 10.2.3 Mexico Intravenous Sets Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Intravenous Sets Consumption (2017-2022)

      • 10.3.2 UK Intravenous Sets Consumption (2017-2022)

      • 10.3.3 Spain Intravenous Sets Consumption (2017-2022)

      • 10.3.4 Belgium Intravenous Sets Consumption (2017-2022)

      • 10.3.5 France Intravenous Sets Consumption (2017-2022)

      • 10.3.6 Italy Intravenous Sets Consumption (2017-2022)

      • 10.3.7 Denmark Intravenous Sets Consumption (2017-2022)

      • 10.3.8 Finland Intravenous Sets Consumption (2017-2022)

      • 10.3.9 Norway Intravenous Sets Consumption (2017-2022)

      • 10.3.10 Sweden Intravenous Sets Consumption (2017-2022)

      • 10.3.11 Poland Intravenous Sets Consumption (2017-2022)

      • 10.3.12 Russia Intravenous Sets Consumption (2017-2022)

      • 10.3.13 Turkey Intravenous Sets Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Intravenous Sets Consumption (2017-2022)

      • 10.4.2 Japan Intravenous Sets Consumption (2017-2022)

      • 10.4.3 India Intravenous Sets Consumption (2017-2022)

      • 10.4.4 South Korea Intravenous Sets Consumption (2017-2022)

      • 10.4.5 Pakistan Intravenous Sets Consumption (2017-2022)

      • 10.4.6 Bangladesh Intravenous Sets Consumption (2017-2022)

      • 10.4.7 Indonesia Intravenous Sets Consumption (2017-2022)

      • 10.4.8 Thailand Intravenous Sets Consumption (2017-2022)

      • 10.4.9 Singapore Intravenous Sets Consumption (2017-2022)

      • 10.4.10 Malaysia Intravenous Sets Consumption (2017-2022)

      • 10.4.11 Philippines Intravenous Sets Consumption (2017-2022)

      • 10.4.12 Vietnam Intravenous Sets Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Intravenous Sets Consumption (2017-2022)

      • 10.5.2 Colombia Intravenous Sets Consumption (2017-2022)

      • 10.5.3 Chile Intravenous Sets Consumption (2017-2022)

      • 10.5.4 Argentina Intravenous Sets Consumption (2017-2022)

      • 10.5.5 Venezuela Intravenous Sets Consumption (2017-2022)

      • 10.5.6 Peru Intravenous Sets Consumption (2017-2022)

      • 10.5.7 Puerto Rico Intravenous Sets Consumption (2017-2022)

      • 10.5.8 Ecuador Intravenous Sets Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Intravenous Sets Consumption (2017-2022)

      • 10.6.2 Kuwait Intravenous Sets Consumption (2017-2022)

      • 10.6.3 Oman Intravenous Sets Consumption (2017-2022)

      • 10.6.4 Qatar Intravenous Sets Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Intravenous Sets Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Intravenous Sets Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Intravenous Sets Consumption (2017-2022)

      • 10.7.2 South Africa Intravenous Sets Consumption (2017-2022)

      • 10.7.3 Egypt Intravenous Sets Consumption (2017-2022)

      • 10.7.4 Algeria Intravenous Sets Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Intravenous Sets Consumption (2017-2022)

      • 10.8.2 New Zealand Intravenous Sets Consumption (2017-2022)

    11 Global Intravenous Sets Competitive Analysis

    • 11.1 Fresenius Kabi

      • 11.1.1 Fresenius Kabi Company Details

      • 11.1.2 Fresenius Kabi Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Fresenius Kabi Intravenous Sets Main Business and Markets Served

      • 11.1.4 Fresenius Kabi Intravenous Sets Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 CareFusion (Becton Dickinson)

      • 11.2.1 CareFusion (Becton Dickinson) Company Details

      • 11.2.2 CareFusion (Becton Dickinson) Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 CareFusion (Becton Dickinson) Intravenous Sets Main Business and Markets Served

      • 11.2.4 CareFusion (Becton Dickinson) Intravenous Sets Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Codan

      • 11.3.1 Codan Company Details

      • 11.3.2 Codan Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Codan Intravenous Sets Main Business and Markets Served

      • 11.3.4 Codan Intravenous Sets Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Hospira

      • 11.4.1 Hospira Company Details

      • 11.4.2 Hospira Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Hospira Intravenous Sets Main Business and Markets Served

      • 11.4.4 Hospira Intravenous Sets Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Smiths Medical

      • 11.5.1 Smiths Medical Company Details

      • 11.5.2 Smiths Medical Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Smiths Medical Intravenous Sets Main Business and Markets Served

      • 11.5.4 Smiths Medical Intravenous Sets Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 ICU Medical

      • 11.6.1 ICU Medical Company Details

      • 11.6.2 ICU Medical Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 ICU Medical Intravenous Sets Main Business and Markets Served

      • 11.6.4 ICU Medical Intravenous Sets Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 B Braun

      • 11.7.1 B Braun Company Details

      • 11.7.2 B Braun Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 B Braun Intravenous Sets Main Business and Markets Served

      • 11.7.4 B Braun Intravenous Sets Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Vygon

      • 11.8.1 Vygon Company Details

      • 11.8.2 Vygon Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Vygon Intravenous Sets Main Business and Markets Served

      • 11.8.4 Vygon Intravenous Sets Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Baxter International

      • 11.9.1 Baxter International Company Details

      • 11.9.2 Baxter International Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Baxter International Intravenous Sets Main Business and Markets Served

      • 11.9.4 Baxter International Intravenous Sets Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Intravenous Sets Market Outlook by Types and Applications to 2028

    • 12.1 Global Intravenous Sets Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Primary IV Sets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Secondary IV Sets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global IV Extensions Sets Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Intravenous Sets Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Congestive Heart Failure Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Immune Deficiencies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Intravenous Sets Market Analysis and Outlook to 2028

    • 13.1 Global Intravenous Sets Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Intravenous Sets Consumption Forecast (2022-2028)

      • 13.2.2 Canada Intravenous Sets Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Intravenous Sets Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.2 UK Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.3 Spain Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.5 France Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.6 Italy Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.8 Finland Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.9 Norway Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.11 Poland Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.12 Russia Intravenous Sets Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Intravenous Sets Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.2 Japan Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.3 India Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Intravenous Sets Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Intravenous Sets Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Intravenous Sets Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Intravenous Sets Consumption Forecast (2022-2028)

      • 13.5.3 Chile Intravenous Sets Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Intravenous Sets Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Intravenous Sets Consumption Forecast (2022-2028)

      • 13.5.6 Peru Intravenous Sets Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Intravenous Sets Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Intravenous Sets Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Intravenous Sets Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Intravenous Sets Consumption Forecast (2022-2028)

      • 13.6.3 Oman Intravenous Sets Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Intravenous Sets Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Intravenous Sets Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Intravenous Sets Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Intravenous Sets Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Intravenous Sets Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Intravenous Sets Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Intravenous Sets Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Intravenous Sets Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Intravenous Sets Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Intravenous Sets

    • Figure of Intravenous Sets Picture

    • Table Global Intravenous Sets Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Intravenous Sets Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Primary IV Sets Consumption and Growth Rate (2017-2022)

    • Figure Global Secondary IV Sets Consumption and Growth Rate (2017-2022)

    • Figure Global IV Extensions Sets Consumption and Growth Rate (2017-2022)

    • Figure Global Congestive Heart Failure Consumption and Growth Rate (2017-2022)

    • Figure Global Crohn's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Hemophilia Consumption and Growth Rate (2017-2022)

    • Figure Global Immune Deficiencies Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Sets Consumption by Country (2017-2022)

    • Table North America Intravenous Sets Consumption by Country (2017-2022)

    • Figure United States Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Canada Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Mexico Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Table Europe Intravenous Sets Consumption by Country (2017-2022)

    • Figure Germany Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure UK Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Spain Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Belgium Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure France Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Italy Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Denmark Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Finland Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Norway Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Sweden Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Poland Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Russia Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Turkey Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Table APAC Intravenous Sets Consumption by Country (2017-2022)

    • Figure China Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Japan Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure India Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Thailand Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Singapore Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Philippines Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Table South America Intravenous Sets Consumption by Country (2017-2022)

    • Figure Brazil Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Colombia Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Chile Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Argentina Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Peru Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Table GCC Intravenous Sets Consumption by Country (2017-2022)

    • Figure Bahrain Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Oman Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Qatar Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Table Africa Intravenous Sets Consumption by Country (2017-2022)

    • Figure Nigeria Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure South Africa Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Egypt Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure Algeria Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Table Oceania Intravenous Sets Consumption by Country (2017-2022)

    • Figure Australia Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Intravenous Sets Consumption and Growth Rate (2017-2022)

    • Table Fresenius Kabi Company Details

    • Table Fresenius Kabi Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi Intravenous Sets Main Business and Markets Served

    • Table Fresenius Kabi Intravenous Sets Product Portfolio

    • Table CareFusion (Becton Dickinson) Company Details

    • Table CareFusion (Becton Dickinson) Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table CareFusion (Becton Dickinson) Intravenous Sets Main Business and Markets Served

    • Table CareFusion (Becton Dickinson) Intravenous Sets Product Portfolio

    • Table Codan Company Details

    • Table Codan Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Codan Intravenous Sets Main Business and Markets Served

    • Table Codan Intravenous Sets Product Portfolio

    • Table Hospira Company Details

    • Table Hospira Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Intravenous Sets Main Business and Markets Served

    • Table Hospira Intravenous Sets Product Portfolio

    • Table Smiths Medical Company Details

    • Table Smiths Medical Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Smiths Medical Intravenous Sets Main Business and Markets Served

    • Table Smiths Medical Intravenous Sets Product Portfolio

    • Table ICU Medical Company Details

    • Table ICU Medical Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICU Medical Intravenous Sets Main Business and Markets Served

    • Table ICU Medical Intravenous Sets Product Portfolio

    • Table B Braun Company Details

    • Table B Braun Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table B Braun Intravenous Sets Main Business and Markets Served

    • Table B Braun Intravenous Sets Product Portfolio

    • Table Vygon Company Details

    • Table Vygon Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vygon Intravenous Sets Main Business and Markets Served

    • Table Vygon Intravenous Sets Product Portfolio

    • Table Baxter International Company Details

    • Table Baxter International Intravenous Sets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International Intravenous Sets Main Business and Markets Served

    • Table Baxter International Intravenous Sets Product Portfolio

    • Figure Global Primary IV Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Secondary IV Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IV Extensions Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Congestive Heart Failure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immune Deficiencies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Table North America Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Figure United States Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Figure Germany Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Figure China Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Figure Brazil Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Intravenous Sets Consumption Forecast by Country (2022-2028)

    • Figure Australia Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Intravenous Sets Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.